1 |
Lichtinghagen, R., P. B. Musholt, M. Lein, A. Romer, B. Rudolph, G. Kristiansen, S. Hauptmann, D. Schnorr, S. A. Loening, and K. Jung. 2002. Different mRNA and protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases 1 in benign and malignant prostate tissue. European Urology 42, 398-406.
DOI
|
2 |
Pastores, G. M., M. J. Patel, and H. Firooznia. 2000. Bone and joint complications related to Gaucher disease. Curr. Rheumatol. Rep. 2, 175-180.
DOI
|
3 |
Roversi, F. M., L. C. Galdieri, B. H. Grego, F. G. Souza, C. Micheletti, A. M. Martins, and V. D'Almeida. 2006. Blood oxidative stress markers in Gaucher disease patients. Clin. Chim. Acta. 364, 316-320.
DOI
|
4 |
Shen, J. S., X. L. Meng, D. F. Moore, J. M. Quirk, J. A. Shayman, R. Schiffmann, and C. R. Kaneski. 2008. Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells. Mol. Genet. Metab. 95, 163-168.
DOI
|
5 |
Wei, H., S. J. Kim, Z. Zhang, P. C. Tsai, K. E. Wisniewski, and A. B. Mukherjee. 2008. ER and oxidative stresses are common mediators of apoptosis in both neurodegenerative and non-neurodegenerative lysosomal storage disorders and are alleviated by chemical chaperones. Hum. Mol. Genet. 17, 469-477.
DOI
|
6 |
Baur, J. A., and D. A. Sinclair. 2006. Therapeutic potential of resveratrol: the in vivo evidence. Nat. Rev. Drug Discov. 5, 493-506.
DOI
|
7 |
Cal, C., H. Garban, A. Jazirehi, C. Yeh, Y. Mizutani, and B. Bonavida. 2003. Resveratrol and cancer: chemoprevention, apoptosis, and chemo-immunosensitizing activities. Curr. Med. Chem. Anticancer Agents 3, 77-93.
DOI
|
8 |
Ahmad, N., V. M. Adhami, F. Afaq, D. K. Feyes, and H. Mukhtar. 2001. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Clin. Cancer Res. 7, 1466-1473.
|
9 |
Almond, J. B., and G. M. Cohen. 2002. The proteasome: a novel target for cancer chemotherapy. Leukemia 16, 433-443.
DOI
|
10 |
Berger, J., S. Lecourt, V. Vanneaux, C. Rapatel, S. Boisgard, C. Caillaud, N. Boiret-Dupre, C. Chomienne, J. P. Marolleau, J. Larghero, and M. G. Berger. Glucocerebrosidase deficiency dramatically impairs human bone marrow haematopoiesis in an in vitro model of Gaucher disease. Br. J. Haematol. 150, 93-101.
|
11 |
Chen, Y., S. H. Tseng, H. S. Lai, and W. J. Chen. 2004. Resveratrol-induced cellular apoptosis and cell cycle arrest in neuroblastoma cells and antitumor effects on neuroblastoma in mice. Surgery 136, 57-66.
DOI
|
12 |
Goker-Alpan, O., R. Schiffmann, J. K. Park, B. K. Stubblefield, N. Tayebi, and E. Sidransky. 2003. Phenotypic continuum in neuronopathic Gaucher disease: an intermediate phenotype between type 2 and type 3. J. Pediatr. 143, 273-276.
DOI
|